Skip to main content
Caplight Logo









Ophthalytics Inc

Ophthalytics Inc

Private
Marietta, GeorgiaHealthcare & Life Scienceshttps://360intelligentdiagnostics.com/

Last Round

Accelerator

Oct 24, 2024

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Ophthalytics Inc is a healthcare technology company that provides an AI-based diagnostic platform for the early detection and diagnosis of ophthalmic diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

diabetic retinopathy screeningAI medical diagnosismedical imaging AIophthalmology AIretinal image analysispoint-of-care diagnosticscomputer visionSaaS platformhealth equity technologypay-per-exam modelusage-based billingcamera-agnosticHIPAA compliantclinical trial supportFDA clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ophthalytics Inc Comparables

Compare Ophthalytics Inc with similar companies based on industry and business-model similarity.

Ophthalytics Inc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RETINA-AI Health
91%
EyRIS Pte Ltd
89%
Eyenuk
89%

Ophthalytics Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 24, 2024
AcceleratorJul 15, 2024
AcceleratorJul 12, 2023

Key People

Founding team and executive leadership

Awais Bajwa

Founder & CEO

Founding Team

Ophthalytics Inc Investors

Notable investors and investment history

Ophthalytics Inc investors
InvestorRounds
Creative Destruction LabAccelerator
MATTERAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Grew 38% QoQ, from 13 to 18 employees.

  • Apr 17, 2026

    Grew 30% QoQ, from 10 to 13 employees.

Ophthalytics Inc Filings

Explore SEC and related filing metadata, where available.

Ophthalytics Inc filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ophthalytics Inc's valuation, stock price, and market status.

Is Ophthalytics Inc a public or private company?

Ophthalytics Inc is a private company.

What is the current stock price of Ophthalytics Inc?

Ophthalytics Inc is a private company with no public stock price. No recent secondary market data is available.

How much is Ophthalytics Inc worth (valuation)?

Valuation information for Ophthalytics Inc is not publicly available.

Can I buy Ophthalytics Inc stock?

Ophthalytics Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ophthalytics Inc's last funding round?

Ophthalytics Inc's most recent funding round was Accelerator on October 24, 2024.

Who are the main investors in Ophthalytics Inc?

Key investors in Ophthalytics Inc include Creative Destruction Lab, MATTER.

Will Ophthalytics Inc IPO soon?

No public IPO plans have been announced for Ophthalytics Inc.

How can I track Ophthalytics Inc secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ophthalytics Inc's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMarietta, Georgia
Employee Range18
Year Founded2020
Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?